期刊文献+

肥胖伴隐匿性高血压患者血清中期因子水平分析 被引量:6

Analysis of Serum Midkine Level in Patients with Masked Hypertension and Obesity
下载PDF
导出
摘要 目的探讨肥胖伴隐匿性高血压(masked hypertension,MH)患者血清中期因子(midkine,MK)水平及临床意义。方法选择诊所血压(CBP)正常的肥胖者100例和体质量正常的健康体检者50例作为对照组,均行24h动态血压监测(ABPM)。按日间血压监测结果,肥胖组被分为肥胖MH组(诊所血压正常,日间动态血压高于正常值)41例和单纯肥胖组59例。采用酶联免疫吸附法检测检测外周血MK含量。对比分析两组血清MK水平及其与日间血压的关系。结果 (1)MK比较:与单纯肥胖组和对照组比较,肥胖MH组血清MK明显升高(P均<0.05);单纯肥胖组与对照组比较差异无统计学意义。(2)血压比较:肥胖MH组的dSBP、dDBP均明显高于单纯肥胖组和对照组(P均<0.01)。Pearson相关分析显示,肥胖MH组血清MK水平与dSBP、dDBP均呈正相关(P均<0.01)。结论肥胖患者MH与血清MK水平有关,MK可能参与了肥胖患者高血压的发生发展过程。 Objective To investigate the level and clinical significance of serum midkine in patients with masked hypertension and obesity.Methods Based on the results of ambulatory blood pressure monitoring (ABPM) and body mass index(BMI),150 subjects with normal clinical blood pressure were divided into three groups,obesity with masked hypertension group(n =41),single obesity group (n =59) and healthy control group(n =50).The level of serum M K was detected by elisa method.The level of three groups'serum M K was compared and the relationship between serum MK level and daytime blood pressure was comparatively analysed.Results (1) MK compare,the serum MK level of obesity with masked hypertension group was significantly higher than that of obesity group (P 〈 0.05).there was no significant difference in serum MK between single obesity group and healthy control group.(2) Blood pressure compare,the dSBP and dDBP of besity with masked hypertension group was significantly higher than that of the other two groups (P 〈 0.01).Pearson correlation analysis indicated that the serum MK level of obesity with masked hypertension group was positively correlated with the level of dSBP (P 〈 0.01) and dDBP (P 〈 0.01).Conclusion The level of serum MK may be associated with masked hypertension and obesity.MK may be involved with the occurrence and development of masked hypertension in obesity patients.
出处 《医学研究杂志》 2013年第9期90-92,共3页 Journal of Medical Research
关键词 肥胖 隐匿性高血压 中期因子 血清 Obesity Masked hypertension Midkine Serum
  • 相关文献

参考文献10

  • 1Schlaich MP, Grassi G, Lambert GW,et al. European Society of Hy- pertension Working Group on Obesity. Obesity - induced hypertension and target organ damage: current knowledge and future directions [ J ]. J Hypertens,2009,27 ( 2 ) : 207 - 211.
  • 2Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white- coat, masked and sustained hypertension versus true normo- tension : a meta - analysis [ J ]. J Hypertens, 2007,25 ( 11 ) : 2193 - 2198.
  • 3Kadomatsu K. The midkine family in cancer, inflammation and neural development[ J ]. Nagoya J Med Sci, 2005,67 ( 3 - 4) :71 - 82.
  • 4Anuurad E, Shiwaku K, Nogi A, et al. The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japa- nese workers[J]. J Occup Health,2003,45 (6):335 -343.
  • 5刘丽芳,谢晋湘,晋库根,王晋祥,牛爱萍,张培湘,杜志凌,刘力生.隐性高血压病人中心动脉压及增强指数[J].高血压杂志,2005,13(12):771-775. 被引量:29
  • 6Bobrie G, Clerson P, Menard J, et al. Masked hypertension: a sys- tematic review [J]. J Hypertens, 2008,26(9) : 1715 -1725.
  • 7Knobler H,Abbasi F,Lamendola C, et al. Insulin resistance and car- diovascular disease risk factors in subjects with prehypertension [ J ]. Diab Vasc Dis Res,2011,8(1) :43 -46.
  • 8Gonzalez - Chavez A, Elizondo - Argueta S, Gutierrez - Reyes G, et al. Pathophysiological implications between chronic inflammation and the development of diabetes and obesity [ J ]. Cir Cir, 2011,79 ( 2 ) : 209 - 216.
  • 9Muramatsu T. Midkine, a heparin - binding cytokine with multiple roles in development, repair and diseases [ J]. Proc Jpn Acad Ser B Phys Biol Sci, 2010,86(4) :410 -425.
  • 10Hobo A, Yuzawa Y, Kosugi T, et al. The growth factor midkine regu- lates the renin -angiotensin system in mice[ J]. J Clin Invest, 2009, 119(6) :1616 - 1625.

二级参考文献14

  • 1Devereux RB,Pickering TG.Ambulatory blood pressure in assessing the cardiac impact and prognosis of hypertension.In:O'Brien E,O' Malley K,eds.Blood pressure Measurement.Handbook of Hypertension[M]//V 14.Amsterdam:Elsevier.1991:261-285.
  • 2《中国高血压防治指南》修订委员会.《中国高血压防治指南》2004年修订版[C].,2004,10..
  • 3Sega R,Trocino G,Lanzarotti A,et al.Alterations of cardiac structure in patients with isolated office,ambulatory,or home hyper tension[J].Circulation,2001,104:1385-1392.
  • 4Enstrom I,Thulin T,Lindholm L,et al.How good are standardized blood pressure recordings for diagnosing hypertension?A comparison between office and ambulatory blood pressure[J].J Hypertens,1991,9:561-566.
  • 5O'Rourker MF,Kelly RP.Wave reflection in the systemic circulation and its implications in ventricular function[J].J Hypertens,1993,11:327-337.
  • 6Safar ME,London GM.Therapeutic studies and arterial stiffness in hypertension:recommendations of the European society of hypertension.The clinical committee of arterial structure and function.Working group on vascular structure and function of the European society of hypertension[J].J Hypertens,2000,18:1527-1535.
  • 7Rowlands DB,Glover DR,Ireland MA,et al.Assessment of left-ventricular mass and its response to antihypertensive treatment[J].Lancet,1982,1:467-470.
  • 8Gosse P,Campobello G,Aonizerate E,et al.Left ventricular hypertrophy in hypertension:correlation with rest,exercise and ambulatory systolic blood pressure[J].J Hypertens,1986,4:S297-299.
  • 9Palatini P,Mornino P,Di Marco A,et al.Ambulatory blood pressure vs causal pressure for the evaluation of target organ damage in hypertension:complications of hypertension[J].J Hypertens,1985,3:S425-427.
  • 10Saba PS,Roman MJ,Pini R,et al.Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects[J].JACC,1993,22:1873-1880.

共引文献28

同被引文献55

  • 1赵亮,谢伟,刘俊明,黄文军.隐蔽性高血压的诊治进展[J].兵团医学,2012(4):49-52. 被引量:1
  • 2王颖,许德兵,张启高.隐匿性高血压的研究进展[J].东南国防医药,2013,15(2):164-166. 被引量:12
  • 3李令华,宋昌稳,黄莉娟,周亚,赵开林,杨成悌,张缤.隐蔽性高血压患者血管活性物质的变化[J].中华高血压杂志,2007,15(9):720-723. 被引量:21
  • 4Tomiyama M,Horio T,Yoshii M,et al.Masked hypertension and target organ damage in treated hypertensive patients[J].Am J Hypertens,2006,19(9):880-886.
  • 5Hulsmans M,Holvoet P.The vicious circle between oxidative stress and inflammation in atherosclerosis[J].J Cell Mol Med,2010,14 (1):70-78.
  • 6Grassi G,Seravalle G,Trevano FQ,et al.Neurogenic abnormalities in masked hypertension[J].Hypertension,2007,50 (3):537-542.
  • 7Pickering TG,DavidsonK,GerinW,et al.Masked Hypertension[J].Hypertension,2002,40 (6):795-796.
  • 8Sega R,Trocino G,Lanzarotti A,et al.Alterations of cardiac structure inpatients with isolated office,ambulatory,or home hypertension:data from the general population (Pressione Arteriose Monitorate E Loro Associazioni[PAMELA] Study)[J].Circulation,2001,104:1385-1392.
  • 9Ohkubo T,Kikuya M,Metoki H,et al.Prognosis of "masked hypertension" and "white-coat " hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study[J].J Am Coll Cardiol,2005,46(3):L508-L515.
  • 10Matsui Y,Eguchi K,Ishikawa J,et al.Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement[J].Am J Hypertens,2007,20(4):385-391.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部